838 related articles for article (PubMed ID: 27612583)
21. Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma.
Zhu YJ; Sun YL; Xia Y; Jiang WQ; Huang JJ; Huang HQ; Lin TY; Guan ZZ; Li ZM
Med Oncol; 2012 Jun; 29(2):1127-33. PubMed ID: 21390515
[TBL] [Abstract][Full Text] [Related]
22. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
[TBL] [Abstract][Full Text] [Related]
25. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.
Younes A; Santoro A; Shipp M; Zinzani PL; Timmerman JM; Ansell S; Armand P; Fanale M; Ratanatharathorn V; Kuruvilla J; Cohen JB; Collins G; Savage KJ; Trneny M; Kato K; Farsaci B; Parker SM; Rodig S; Roemer MG; Ligon AH; Engert A
Lancet Oncol; 2016 Sep; 17(9):1283-94. PubMed ID: 27451390
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
Sanna G; Lorizzo K; Rotmensz N; Bagnardi V; Cinieri S; Colleoni M; Nolè F; Goldhirsch A
Ann Oncol; 2007 Feb; 18(2):288-92. PubMed ID: 17088328
[TBL] [Abstract][Full Text] [Related]
27. The interplay between cancer-related fatigue and functional health in Hodgkin lymphoma survivors.
Stadtbaeumer N; Müller H; Goergen H; Kreissl S; Borchmann P; Mayer A
Health Psychol; 2020 Oct; 39(10):905-911. PubMed ID: 32496079
[TBL] [Abstract][Full Text] [Related]
28. Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
Bröckelmann PJ; Goergen H; Fuchs M; Kriz J; Semrau R; Baues C; Kobe C; Behringer K; Eichenauer DA; von Tresckow B; Klimm B; Halbsguth T; Wongso D; Plütschow A; Haverkamp H; Dietlein M; Eich HT; Stein H; Diehl V; Borchmann P; Engert A
Br J Haematol; 2015 Nov; 171(4):547-56. PubMed ID: 26310520
[TBL] [Abstract][Full Text] [Related]
29. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
Busson R; van der Kaaij M; Mounier N; Aleman BMP; Thiéblemont C; Stamatoullas A; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Kluin-Nelemans HC; Henry-Amar M
Health Qual Life Outcomes; 2019 Jul; 17(1):115. PubMed ID: 31266501
[TBL] [Abstract][Full Text] [Related]
30. Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B.
Kornblith AB; Herndon JE; Zuckerman E; Cella DF; Cherin E; Wolchok S; Weiss RB; Diehl LF; Henderson E; Cooper MR; Schiffer C; Canellos GP; Mayer RJ; Silver RT; Schilling A; Peterson BA; Greenberg D; Holland JC
Ann Oncol; 1998 Mar; 9(3):297-306. PubMed ID: 9602264
[TBL] [Abstract][Full Text] [Related]
31. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
[TBL] [Abstract][Full Text] [Related]
32. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
[TBL] [Abstract][Full Text] [Related]
33. Hodgkin's disease: quality of life in future trials.
Kaasa S; Knobel H; Loge JH; Hjermstad MJ
Ann Oncol; 1998; 9 Suppl 5():137-45. PubMed ID: 9926254
[TBL] [Abstract][Full Text] [Related]
34. Quality control of involved field radiotherapy in the HD 13 and HD 14 trials : Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG).
Kriz J; Baues C; Engenhart-Cabillic R; Haverkamp U; Herfart K; Lukas P; Plütschow A; Schmidberger H; Staar S; Fuchs M; Engert A; Eich HT
Strahlenther Onkol; 2017 Feb; 193(2):109-115. PubMed ID: 27596217
[TBL] [Abstract][Full Text] [Related]
35. [Deterioration of quality of life in patients with Hodgkin lymphoma in the 5 years after treatment completion: long-term data from the HD13, HD14 and HD15 studies].
Vordermark D
Strahlenther Onkol; 2021 May; 197(5):449-451. PubMed ID: 33754162
[No Abstract] [Full Text] [Related]
36. Predictors of fatigue and poor sleep in adult survivors of childhood Hodgkin's lymphoma: a report from the Childhood Cancer Survivor Study.
Rach AM; Crabtree VM; Brinkman TM; Zeltzer L; Marchak JG; Srivastava D; Tynes B; Lai JS; Robison LL; Armstrong GT; Krull KR
J Cancer Surviv; 2017 Apr; 11(2):256-263. PubMed ID: 27837445
[TBL] [Abstract][Full Text] [Related]
37. Fatigue in long-term Hodgkin's Disease survivors: a follow-up study.
Hjermstad MJ; Fosså SD; Oldervoll L; Holte H; Jacobsen AB; Loge JH
J Clin Oncol; 2005 Sep; 23(27):6587-95. PubMed ID: 16170166
[TBL] [Abstract][Full Text] [Related]
38. Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.
van der Kaaij MA; Heutte N; Meijnders P; Abeilard-Lemoisson E; Spina M; Moser EC; Allgeier A; Meulemans B; Simons AH; Lugtenburg PJ; Aleman BM; Noordijk EM; Fermé C; Thomas J; Stamatoullas A; Fruchart C; Brice P; Gaillard I; Bologna S; Ong F; Eghbali H; Doorduijn JK; Morschhauser F; Sebban C; Roesink JM; Bouteloup M; Van Hoof A; Raemaekers JM; Henry-Amar M; Kluin-Nelemans HC
J Clin Oncol; 2012 Jan; 30(3):291-9. PubMed ID: 22184372
[TBL] [Abstract][Full Text] [Related]
39. A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue.
Ng AK; Li S; Recklitis C; Neuberg D; Chakrabarti S; Silver B; Diller L
Ann Oncol; 2005 Dec; 16(12):1949-55. PubMed ID: 16227316
[TBL] [Abstract][Full Text] [Related]
40. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
